trending Market Intelligence /marketintelligence/en/news-insights/trending/JxEPPGtwhUaeg-qm3xMh1A2 content esgSubNav
In This List

Bluebird Bio starts common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Bluebird Bio starts common stock offering

Bluebird Bio Inc. started an underwritten public offering for $600 million of its common stock.

The company will grant the underwriters an option to buy up to an additional 15% of the common shares offered.

Goldman Sachs & Co. LLC, Bank of America Merrill Lynch, J.P. Morgan Securities LLC and Cowen are acting as joint book-running managers of the proposed offering.